291 Predictive genetic biomarkers for the development of peritoneal metastases in colorectal cancer [17] Roth, L.; Russo, L.; Ulugoel, S.; Freire Dos Santos, R.; Breuer, E.; Gupta, A.; Lehmann, K. Peritoneal Metastasis: Current Status and Treatment Options. Cancers 2021, 14, 60. https://doi. org/10.3390/cancers14010060. [18] Schneider, M.A.; Eden, J.; Pache, B.; Laminger, F.; Lopez-Lopez, V.; Steffen, T.; Hübner, M.; Kober, F.; Roka, S.; Campos, P.C.; et al. Mutations of RAS/RAF Proto-oncogenes Impair Survival after Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin. Ann. Surg. 2018, 268, 845–853. https://doi.org/10.1097/ sla.0000000000002899. [19] Heuvelings, D.J.I.; Wintjens, A.; Luyten, J.; Wilmink, G.; Moonen, L.; Speel, E.M.; de Hingh, I.; Bouvy, N.D.; Peeters, A. DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review. Cancers 2023, 15, 549. https://doi.org/10.3390/cancers15020549. [20] Riley, R.D.; Ensor, J.; Snell, K.I.E.; Harrell, F.E.; Martin, G.P.; Reitsma, J.B.; Moons, K.G.M.; Collins, G.; van Smeden, M. Calculating the sample size required for developing a clinical prediction model. BMJ 2020, 368, m441. https://doi. org/10.1136/bmj.m441. [21] Verkouteren, B.J.; Roemen, G.M.; Schuurs-Hoeijmakers, J.H.; Abdul Hamid, M.; van Geel, M.; Speel, E.M.; Mosterd, K. Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome. J. Clin. Pathol. 2022, 76, 345–348. https://doi.org/10.1136/jcp-2022208391. [22] Mi, H.; Ebert, D.; Muruganujan, A.; Mills, C.; Albou, L.-P.; Mushayamaha, T.; Thomas, P.D. PANTHER version 16: A revised family classification, tree-based classification tool, enhancer regions and extensive API. Nucleic Acids Res. 2020, 49, D394–D403. https://doi.org/10.1093/ nar/gkaa1106. [23] Gene Ontology Consortium. The Gene Ontology resource: Enriching a GOld mine. Nucleic Acids Res. 2021, 49, D325–D334. https://doi. org/10.1093/nar/gkaa1113. [24] Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.; Dwight, S.S.; Eppig, J.T.; et al. Gene Ontology: Tool for the unification of biology. Nat. Genet. 2000, 25, 25–29. https://doi. org/10.1038/75556. [25] Jassal, B.; Matthews, L.; Viteri, G.; Gong, C.; Lorente, P.; Fabregat, A.; Sidiropoulos, K.; Cook, J.; Gillespie, M.; Haw, R. The reactome pathway knowledgebase. Nucleic Acids Res. 2020, 48, D498–D503. [26] Zhang, Y.; Qin, X.; Chen, W.; Liu, D.; Luo, J.; Wang, H.; Wang, H. Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta-analysis. Color. Dis. 2021, 23, 2846–2858. https://doi.org/10.1111/codi.15880. [27] Segelman, J.; Granath, F.; Holm, T.; Machado, M.; Mahteme, H.; Martling, A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 2012, 99, 699–705. https://doi.org/10.1002/bjs.8679. [28] Klaver, C.E.L.; Wisselink, D.D.; Punt, C.J.A.; Snaebjornsson, P.; Crezee, J.; Aalbers, A.G.J.; Brandt, A.; Bremers, A.J.A.; Burger, J.W.A.; Fabry, H.F.J.; et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): A multicentre, open-label, randomised trial. Lancet Gastroenterol. Hepatol. 2019, 4, 761–770. https://doi.org/10.1016/S2468-1253(19)302390. [29] Arjona-Sánchez, A.; Barrios, P.; Boldo-Roda, E.; Camps, B.; Carrasco-Campos, J.; Concepción Martín, V.; García-Fadrique, A.; Gutiérrez-Calvo, A.; Morales, R.; Ortega-Pérez, G.; et al. HIPECT4: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma. BMC Cancer 2018, 18, 183. https://doi.org/10.1186/ s12885-018-4096-0. [30] Karunasena, E.; Sham, J.; McMahon, K.W.; Ahuja, N. Genomics of Peritoneal Malignancies. Surg. Oncol. Clin. N. Am. 2018, 27, 463–475. https:// doi.org/10.1016/j.soc.2018.02.004. [31] Fodde, R. The APC gene in colorectal cancer. Eur. J. Cancer 2002, 38, 867–871. https://doi. org/10.1016/s0959-8049(02)00040-0. [32] Zhang, L.; Shay, J.W. Multiple Roles of APC and Its Therapeutic Implications in Colorectal Cancer. JNCI J. Natl. Cancer Inst. 2017, 109, djw332. https://doi.org/10.1093/jnci/djw332. [33] Lipsyc, M.; Yaeger, R. Impact of somatic mutations on patterns of metastasis in colorectal cancer. J. Gastrointest. Oncol. 2015, 6, 645–649. https://doi.org/10.3978/j.issn.20786891.2015.045. [34] Lan, Y.T.; Jen-Kou, L.; Lin, C.H.; Yang, S.H.; Lin, C.C.; Wang, H.S.; Chen, W.S.; Lin, T.C.; Jiang, J.K.; Chang, S.C. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers. J. Surg. Oncol. 2015, 111, 905–910. https://doi.org/10.1002/jso.23895. 12
RkJQdWJsaXNoZXIy MTk4NDMw